Persistent Corneal Epithelial Defect Clinical Trials

13 clinical trials for Persistent Corneal Epithelial Defect across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED) — RECRUITING · PHASE3
• An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED — RECRUITING · PHASE3
• Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects — RECRUITING · PHASE4
• Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED — RECRUITING · PHASE2
• Multicenter, controlled, randomized, observer-blinded clinical trial to evaluate the efficacy and safety of insulin eye drops (1 IU/ml) in the treatment of persistent corneal epithelial defect. — TERMINATED · PHASE3
• Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED — TERMINATED · PHASE2
• A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects — COMPLETED · PHASE2
• ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects — TERMINATED · PHASE2
• Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers — WITHDRAWN · PHASE2
• ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects — COMPLETED · PHASE2
• Autologous Platelet Lysate in Corneal Epithelial Defects — COMPLETED · PHASE1
• Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect — COMPLETED · PHASE2

Refine this search